Lee Danner & Bass Inc reports 3.30% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Lee Danner & Bass Inc
Latest Disclosed Ownership	31,841 shares
Latest Disclosed Value	$ 1,931,150

On April 28, 2026 - Lee Danner & Bass Inc filed a 13F-HR form disclosing ownership of 31,841 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,669,105 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 32,928 shares of Bristol-Myers Squibb Company. This represents a change in shares of -3.30% during the quarter. The current value of the position is $1,510,219 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-28	2026-03-31	13F	BRISTOL-MYERS SQUIBB	Stock	110122108	31,841	-1,087	-3.30	1,931	8.73	0.1213
2026-01-29	2025-12-31	13F	BRISTOL-MYERS SQUIBB	Stock	110122108	32,928	-366	-1.10	1,776	18.32	0.1273
2025-10-29	2025-09-30	13F	BRISTOL-MYERS SQUIBB	Stock	110122108	33,294	1,561	4.92	1,502	2.25	0.1093
2025-07-31	2025-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	31,733	0	0.00	1,469	-24.13	0.1143
2025-04-29	2025-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	31,733	-110	-0.35	1,935	7.44	0.1565
2025-02-11	2024-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	Stock	110122108	31,843	-258	-0.80	1,801	180,000.00	0.1427
2024-10-30	2024-09-30	13F	Bristol Myers Squibb	COM	110122108	32,101	569	1.80	2	0.00	0.1170
2024-07-30	2024-06-30	13F	Bristol Myers Squibb	COM	110122108	31,532	-14,321	-31.23	1	-50.00	0.1010
2024-02-01	2023-12-31	13F	Bristol Myers Squibb	COM	110122108	45,853	-24,621	-34.94	2	-50.00	0.2016
2023-10-27	2023-09-30	13F	Bristol Myers Squibb	COM	110122108	70,474	-2,256	-3.10	4	0.00	0.3704
2023-07-31	2023-06-30	13F	Bristol Myers Squibb	COM	110122108	72,730	-2,320	-3.09	5	-20.00	0.4001
2023-05-02	2023-03-31	13F	Bristol Myers Squibb	COM	110122108	75,050	-190	-0.25	5	0.00	0.4785
2023-02-01	2022-12-31	13F	Bristol Myers Squibb	COM	110122108	75,240	-226	-0.30	5	-99.91	0.5107
2022-10-31	2022-09-30	13F	Bristol Myers Squibb	COM	110122108	75,466	-517	-0.68	5,365	-8.31	0.5672
2022-07-25	2022-06-30	13F	Bristol Myers Squibb	COM	110122108	75,983	-1,135	-1.47	5,851	3.89	0.5911
2022-04-27	2022-03-31	13F	Bristol Myers Squibb	COM	110122108	77,118	-1,765	-2.24	5,632	14.52	0.4799
2022-01-27	2021-12-31	13F	Bristol Myers Squibb	COM	110122108	78,883	-8,075	-9.29	4,918	-4.41	0.4210
2021-11-01	2021-09-30	13F	Bristol Myers Squibb	COM	110122108	86,958	4,213	5.09	5,145	-6.95	0.4746
2021-07-27	2021-06-30	13F	Bristol Myers Squibb	COM	110122108	82,745	-1,472	-1.75	5,529	3.99	0.5010
2021-04-29	2021-03-31	13F	Bristol Myers Squibb	COM	110122108	84,217	378	0.45	5,317	2.23	0.5120
2021-02-09	2020-12-31	13F	Bristol Myers Squibb	COM	110122108	83,839	-1,359	-1.60	5,201	1.25	0.5547
2020-11-12	2020-09-30	13F	Bristol Myers Squibb	COM	110122108	85,198	-5,120	-5.67	5,137	-3.28	0.6084
2020-08-10	2020-06-30	13F	Bristol Myers Squibb	COM	110122108	90,318	24,849	37.96	5,311	45.55	0.6773
2020-05-04	2020-03-31	13F	Bristol Myers Squibb	COM	110122108	65,469	3,595	5.81	3,649	-8.13	0.5222
2020-02-13	2019-12-31	13F	Bristol Myers Squibb	COM	110122108	61,874	17,136	38.30	3,972	75.06	0.4155
2019-10-30	2019-09-30	13F	Bristol Myers Squibb	COM	110122108	44,738	100	0.22	2,269	12.10	0.2435
2019-07-30	2019-06-30	13F	Bristol Myers Squibb	COM	110122108	44,638	0	0.00	2,024	-4.98	0.2140
2019-05-06	2019-03-31	13F	Bristol Myers Squibb	COM	110122108	44,638	-175	-0.39	2,130	-8.54	0.2347
2019-01-29	2018-12-31	13F	Bristol Myers Squibb	COM	110122108	44,813	-403	-0.89	2,329	-17.03	0.2741
2018-11-06	2018-09-30	13F	Bristol Myers Squibb	COM	110122108	45,216	-125	-0.28	2,807	11.88	0.2784
2018-11-02	2018-06-30	13F/A-1	Bristol Myers Squibb	COM	110122108	45,341	0	0.00	2,509	-12.52	0.2671
2018-08-06	2018-06-30	13F	Bristol Myers Squibb	COM	110122108	45,341	0		2,664
2018-05-02	2018-03-31	13F	Bristol Myers Squibb	COM	110122108	45,341	3	0.01	2,868	3.24	0.2986
2018-02-02	2017-12-31	13F	Bristol Myers Squibb	COM	110122108	45,338	-1,966	-4.16	2,778	-7.86	0.2824
2017-10-27	2017-09-30	13F	Bristol Myers Squibb	COM	110122108	47,304	1,185	2.57	3,015	17.32	0.3245
2017-07-27	2017-06-30	13F	Bristol Myers Squibb	COM	110122108	46,119	-246	-0.53	2,570	1.94	0.2885
2017-05-23	2017-03-31	13F/A-1	Bristol Myers Squibb	COM	110122108	46,365	-973	-2.06	2,521	-8.86	0.2844
2017-05-04	2017-03-31	13F	Bristol Myers Squibb	COM	110122108	46,365			2,521
2017-01-30	2016-12-31	13F	Bristol Myers Squibb	COM	110122108	47,338	2,720	6.10	2,766	14.96	0.3253
2016-10-26	2016-09-30	13F	Bristol Myers Squibb	COM	110122108	44,618	600	1.36	2,406	-25.69	0.2932
2016-08-02	2016-06-30	13F	Bristol Myers Squibb	COM	110122108	44,018	424	0.97	3,238	4.82	0.3921
2016-04-27	2016-03-31	13F	Bristol Myers Squibb	COM	110122108	43,594	0	0.00	3,089	3.00	0.3794
2016-02-01	2015-12-31	13F	Bristol Myers Squibb	COM	110122108	43,594	0	0.00	2,999	16.20	0.3924
2015-11-03	2015-09-30	13F	Bristol Myers Squibb	COM	110122108	43,594	9	0.02	2,581	-11.00	0.3444
2015-08-05	2015-06-30	13F	Bristol Myers Squibb	COM	110122108	43,585	0	0.00	2,900	3.17	0.3457
2015-05-05	2015-03-31	13F	Bristol Myers Squibb	COM	110122108	43,585	43,585	0.00	2,811		0.3315
2015-02-05	2014-12-31	13F	Bristol Myers Squibb	COM	110122108	0	-43,678	-100.00	0	-100.00
2014-10-28	2014-09-30	13F	Bristol Myers Squibb	COM	110122108	43,678	2,583	6.29	2,235	12.09	0.2763
2014-08-04	2014-06-30	13F	Bristol Myers Squibb	COM	110122108	41,095	2,859	7.48	1,994	0.40	0.2432
2014-05-01	2014-03-31	13F	Bristol Myers Squibb	COM	110122108	38,236	0	0.00	1,986	-2.26	0.2578
2014-02-06	2013-12-31	13F	Bristol Myers Squibb	COM	110122108	38,236	942	2.53	2,032	17.73	0.2711
2013-10-31	2013-09-30	13F	Bristol Myers Squibb	COM	110122108	37,294	0	0.00	1,726	3.54	0.2402
2013-08-07	2013-06-30	13F	Bristol Myers Squibb	COM	110122108	37,294	37,294		1,667		0.2430

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.